<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Pharm Sci</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Pharm Sci</journal-id><journal-id journal-id-type="publisher-id">IJPhS</journal-id><journal-title-group><journal-title>Indian Journal of Pharmaceutical Sciences</journal-title></journal-title-group><issn pub-type="ppub">0250-474X</issn><issn pub-type="epub">1998-3743</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23626391</article-id><article-id pub-id-type="pmc">3630731</article-id><article-id pub-id-type="publisher-id">IJPhS-74-351</article-id><article-id pub-id-type="doi">10.4103/0250-474X.107070</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Procyanidin B2 Cytotoxicity to MCF-7 Human Breast Adenocarcinoma Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Avelar</surname><given-names>Monalisa M.</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gouv&#x000ea;a</surname><given-names>Cibele M. C. P.</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1">Laborat&#x000f3;rio de Cultura de C&#x000e9;lulas, Instituto de Ci&#x000ea;ncias da Natureza, Unifal-MG, Alfenas, Minas Gerais 37130-000, Brazil</aff><author-notes><corresp id="cor1"><label>*</label><bold>Address for correspondence</bold> E-mail: <email xlink:href="cibelegouvea@hotmail.com">cibelegouvea@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2012</year></pub-date><volume>74</volume><issue>4</issue><fpage>351</fpage><lpage>355</lpage><history><date date-type="received"><day>17</day><month>10</month><year>2011</year></date><date date-type="rev-recd"><day>31</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>04</day><month>8</month><year>2012</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Pharmaceutical Sciences</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Procyanidins have attracted some attention due to their demonstrated chemopreventive action, a relatively new and promising strategy to prevent cancer. Breast cancer is one of the leading causes of death in women worldwide and its treatment needs improvements. The aim of this work was to verify the procyanidin dimmer B2 cytotoxic effect to MCF-7 human breast cancer cells. MCF-7 cells were cultured in RPMI medium, containing 20% fetal bovine serum and antibiotics in a CO<sub>2</sub> chamber. The cells were treated with different concentrations of B2 and its cytotoxic potential was assessed by the sulforhodamine B assay, morphologically through haematoxylin-eosin staining and by DNA fragmentation analysis. The significance of differences between experimental conditions was determined using the ANOVA test, followed by the Tukey test when <italic>P</italic>&#x0003c;0.05. Cell proliferation decreased in a concentration and time-dependent manner upon procyanidin dimmer B2 treatment, being 19.20 &#x003bc;M the IC<sub>50</sub>. Procyanidin dimmer B2 treatment displayed concentration and time-dependent decline in MCF-7 cells compared to control and also induced morphological alterations compatible with cell-death induction. Cell condensation and cell diameter decreased (3.5 folds compared to control cells), after 48 h cell-exposure to 50 &#x003bc;M procyanidin dimmer B2, but the DNA ladder formation was not observed. In conclusion, our results demonstrated that procyanidin dimmer B2 exhibits cytotoxic activity to MCF-7 cells and it could be a potential antineoplastic agent. Further studies are necessary to clarify the procyanidin dimmer B2 mechanism of action. The evaluation of biological efficacy of individual components is an important step towards drug discovery and development.</p></abstract><kwd-group><kwd>Cell death</kwd><kwd>phenolic compounds</kwd><kwd>proanthocyanidin</kwd><kwd>tumour cell culture</kwd></kwd-group></article-meta></front><body><p>Breast cancer is one of the leading causes of deaths in women and despite the improvements in diagnosis and treatment of this disease in the last years, the survival rates remain low in comparison with other cancers[<xref ref-type="bibr" rid="ref1">1</xref>]. Mammary cancers exhibit remarkable heterogeneity not only with respect to oestrogen (ER), progesterone (PR) and human epidermal growth factor-2 (HER-2) receptors expression but also with respect to tumour size, grade and nodal status. Thus, breast cancer is a mixture of diverse phenotypes, which raises different treatment needs[<xref ref-type="bibr" rid="ref2">2</xref>] and at the present moment, there is no cure for metastatic breast cancer[<xref ref-type="bibr" rid="ref3">3</xref>], thus justifying the search for new drugs for the treatment and control of this disease.</p><p>It has been reported that some procyanidins, both natural and synthetic, exhibit anticancer activity[<xref ref-type="bibr" rid="ref4">4</xref>&#x02013;<xref ref-type="bibr" rid="ref15">15</xref>]. In a report[<xref ref-type="bibr" rid="ref16">16</xref>], several red wines were fractionated and the authors proved that procyanidin B dimer mixture exhibited aromatase-inhibition activity. This report also demonstrated that the oral intake of procyanidin B dimer mixture was effective in suppressing 62.5% tumour formation in MCF-7-aro cells-injected animals. On the other hand, the procyanidin B dimer mixture was not able to suppress the formation of tumours induced <italic>in vivo</italic> by nontransfected cells. Procyanidin B3 treatment inhibited acetylation-dependent prostate cell proliferation and expression of cell-cycle control genes, subsequently increasing the death of cultured LNCaP and PC-3 prostate cancer cell lines[<xref ref-type="bibr" rid="ref17">17</xref>]. It was found that galloilation of procyanidin B2 improves its cytotoxic activity, and procyanidin B2-3,3&#x02032;-di-<italic>O</italic>-gallate was more cytotoxic to DU145 prostate cancer cell line than procyanidin B2[<xref ref-type="bibr" rid="ref18">18</xref>]. This cytotoxic activity was further confirmed using the LNCaP androgen-dependent human prostate carcinoma cells[<xref ref-type="bibr" rid="ref19">19</xref>]. Zhao <italic>et al</italic>.[<xref ref-type="bibr" rid="ref20">20</xref>] have demonstrated that the ethyl acetate fraction from litchi pericarp extract was cytotoxic to MCF-7 cells and the fraction showed three major constituents: Epicatechin, proanthocyanidin B2 and proanthocyanidin B4.</p><p>The aim of the present work was to evaluate the procyanidin B2 cytotoxic activity to MCF-7 cells that express the oestrogen receptor &#x003b1; (ER+), a model for the human <italic>in situ</italic> breast carcinoma.</p><p>Procyanidin B2 (B2) and cyclophosphamide (CP) were purchased from Sigma Chemical Co., USA. Roswell Park Memorial Institute 1640 (RPMI) culture medium, fetal bovine serum and antibiotics were from Cultilab, USA. The MCF-7 human breast adenocarcinoma cell line was purchased from the Rio de Janeiro Cell Bank, Brazil.</p><p>MCF-7 cells were grown in 5 ml of RPMI 1640 medium supplemented with 20% fetal bovine serum, penicillin (100 U/ml) and streptomycin (100 &#x003bc;g/ml). Cells were maintained at 37&#x000b0; in a humidified atmosphere of 5% CO<sub>2</sub> in air and subcultured every 3 days. Exponentially growing cells were plated at a seeding density of 2&#x000d7;10<sup>4</sup> cells/ml, in 96-well plates or in Petri dishes. After overnight incubation to allow for attachment, the cells were exposed for 24 or 48 h to various concentrations of B2 (0.5; 1.0; 5.0; 10.0; 25.0 and 50.0 &#x003bc;M) diluted in distilled water. Two millimolar CP was used as the positive control and solutions were sterilised by filtration.</p><p>Cell proliferation was determined by using sulforhodamine B (SRB) assay, after 24 and 48 h B2 incubation[<xref ref-type="bibr" rid="ref21">21</xref>], with modifications. At the end of the incubation time, the medium was removed and a solution of trichloroacetic acid (10% w/v) was added to each well following incubation for 30 min at 4&#x000b0;. Cells were washed, dried and stained with 0.4% SRB and the solubilised product was measured at 510 nm on a Microplate reader (Asys UVM340). The control cells absorbance was considered 100% of cell proliferation, and to assess the effect of B2 on the cells, the proliferation percentage was calculated by comparing the absorbance of treated versus control cells and the IC<sub>50</sub> was calculated. IC<sub>50</sub> value was defined as the drug concentration needed to inhibit cell proliferation to 50% of control. Results are mean of three independent experiments, with standard errors lower than 5%.</p><p>Haematoxylin-eosin (HE) staining of cells for morphological studies was performed as previously reported[<xref ref-type="bibr" rid="ref22">22</xref>], with modifications. After the incubation of cells plated on sterile microscope cover glass in Petri dishes, they were washed with 0.1 M PBS, pH 7.4, fixed with 70% acetone, dehydrated with ethanol series and HE staining was performed. Slides were mounted in Entellan, observed under a light Olympus BX 52 microscope and photographed. The cell diameter was determined using the Motic Plus 2.0 software for image analysis.</p><p>DNA ladder formation was detected by agarose gel electrophoresis after 24 and 48 h of B2 exposure. The DNA was isolated as previously reported[<xref ref-type="bibr" rid="ref23">23</xref>], with minor modifications. Briefly, the cells were treated with the lysis buffer (25 mM Tris&#x02013;HCl pH 7.8, 25 mM EDTA, 0.5% Triton X-100) at room temperature for 1 h. After centrifugation at 1000 &#x000d7; g, RNase-A (50 &#x003bc;g/ml) was added to the supernatant for 1 h at 37&#x000b0; followed by Proteinase-K (100 &#x003bc;g/ml) for 1 h at 65&#x000b0;. DNA was extracted using phenol&#x02013;chloroform and precipitated with 3 M sodium acetate and chilled absolute ethanol. The pelleted DNA was dissolved in Tris&#x02013;EDTA (pH 8.0) and electrophoresed on 0.8% agarose gel prestained with ethidium bromide (0.5 &#x003bc;g/ml).</p><p>Data were represented as mean&#x000b1;SEM of determinations from three independent experiments. The significance of differences between experimental conditions was determined using the ANOVA test, followed by Tukey test when <italic>P</italic>&#x0003c;0.05.</p><p>For analysing the individual effect of B2 (<xref ref-type="fig" rid="F1">fig. 1</xref>) on cell proliferation, SRB assay was performed. The results demonstrated B2 mediated concentration and time-dependent decline in the MCF-7 cell proliferation versus untreated control (<xref ref-type="fig" rid="F2">fig. 2</xref>). After 24 h exposure, B2 exhibited little effect, but it was enhanced after 48 h, being 19.21 &#x003bc;M the IC<sub>50</sub>. These results demonstrate the B2 antiproliferative activity to MCF-7 cells.</p><fig id="F1" position="float"><label>Fig. 1</label><caption><p>Structure of procyanidin B2.</p><p>(4, 8 &#x02033; - bi - [( + ) - epicatechin], cis, cis &#x02033; - 4, 8&#x02033; - Bi (3, 3&#x02032;, 4&#x02032;, 5, 7-pentahydroxyflavane)</p></caption><graphic xlink:href="IJPhS-74-351-g001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><graphic xlink:href="IJPhS-74-351-g002"/></fig><p>Our results are in agreement with previously published works regarding procyanidin dimer B <italic>in vitro</italic> cytotoxicity to cancer cell lines. A mixture of procyanidin dimer B exhibited aromatase-inhibition activity to the transfected MCF-7-aro cells and this activity was confirmed <italic>in vivo</italic>[<xref ref-type="bibr" rid="ref16">16</xref>]. Procyanidin B3 treatment increased LNCaP cell death by approximately 95% at 100 &#x003bc;M and it acted as a specific histone acetyltransferase inhibitor[<xref ref-type="bibr" rid="ref17">17</xref>]. It has been demonstrated that galloilation of the procyanidin B2 increased its toxicity to cancer cells[<xref ref-type="bibr" rid="ref18">18</xref><xref ref-type="bibr" rid="ref19">19</xref>]. The ethyl acetate fraction from litchi pericarp extract exhibited cytotoxicity to MCF-7 cells and the fraction constituents, Epicatechin and proanthocyanidin B2 showed higher cytotoxicity than that of proanthocyanidin B4 and the ethyl acetate fraction[<xref ref-type="bibr" rid="ref20">20</xref>].</p><p>The results of the HE staining studies (<xref ref-type="fig" rid="F3">fig. 3</xref>) showed cell morphology changes. The control cells show an irregular shape and a colony growth pattern. The 0.5 &#x003bc;M B2-treatment produced little effect, however, 50.0 &#x003bc;M B2-treatment decreased cell size, induced the loss of sprouts responsible for substrate attachment, cells became round, and intensively stained. The measurement of cell diameter showed that the 50 &#x003bc;M of B2 was more cytotoxic than CP to MCF-7 cells 
(<xref ref-type="fig" rid="F4">fig. 4</xref>), reducing 3.5-fold the diameter of B2-treated cells in comparison to control cells. Collectively, the morphological alterations observed in the present work indicate MCF-7 cell-death induction.</p><fig id="F3" position="float"><label>Fig. 3</label><caption><p>MCF-7 cell morphology.</p><p>MCF-7 cell morphology after 24 or 48 h growth, stained with hematoxylin-eosin. Control cells (C); Cells treated with 2 mM cyclophosphamide (CP); 0.5 &#x003bc;M (B2 0.5) and 50.0 &#x003bc;M (B2 50.0) procyanidin B2. All pictures are typical of three independent experiments each performed under identical conditions. Bar = 10 &#x003bc;m. Note the cell diameter reduction, especially in CP and B2 50.0 groups</p></caption><graphic xlink:href="IJPhS-74-351-g003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><graphic xlink:href="IJPhS-74-351-g004"/></fig><p>We next investigated if B2 treatment induced DNA fragmentation, a common feature in apoptosis. However, alterations in nuclear morphology may not necessarily involve DNA fragmentation[<xref ref-type="bibr" rid="ref24">24</xref>]. Despite the B2 cytotoxicity observed towards MCF-7 cells, no DNA-ladder formation (<xref ref-type="fig" rid="F5">fig. 5</xref>) was observed upon the treatment of cells with B2 and even with CP, an anticancer drug that has been reported to be apoptotic to MCF-7 cells[<xref ref-type="bibr" rid="ref25">25</xref><xref ref-type="bibr" rid="ref26">26</xref>]. It has been reported that MCF-7 lack caspase-3 activity and caspase-3 activity is essential for the DNA-ladder pattern formation[<xref ref-type="bibr" rid="ref27">27</xref>].</p><fig id="F5" position="float"><label>Fig. 5</label><caption><p>Agarose gel electrophoresis for genomic DNA extract.</p><p>Agarose gel electrophoresis (0.8%), stained with ethidium bromide, of genomic DNA extracted from control, 2 mM cyclophosphamide (CP) and procyanidin B2 (B2) treated MCF-7 cells, for 24 or 48 h. 1, 123 bp ladder marker; 2, Control; 3, CP; 4, 0.5 &#x003bc;M B2; 5, 1.0 &#x003bc;M B2; 6, 5.0 &#x003bc;M B2; 7, 10.0 &#x003bc;M B2; 8, 25.0 &#x003bc;M B2; 9, 50.0 &#x003bc;M B2. Note that no DNA fragmentation can be seeing</p></caption><graphic xlink:href="IJPhS-74-351-g005"/></fig><p>The results of this work indicate that B2 is a potential antineoplastic agent and could be used for the treatment and control of breast cancer. Studies are in progress in our laboratory to identify the cell-death pathway elicited by B2.</p></body><back><ack><title>ACKNOWLEDGEMENTS</title><p>The authors are thankful to FAPEMIG for financial support (Grant No. 1305/06), UNIFAL-MG for MMA fellowship and PET-MEC-SESU for CMCPG fellowship.</p></ack><fn-group><fn fn-type="other"><p>Avelar and Gouv&#x000ea;a: Procyanidin B2 Cytotoxicity to MCF-7 Cells</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Center</surname><given-names>MM</given-names></name><name><surname>DeSantis</surname><given-names>C</given-names></name><name><surname>Ward</surname><given-names>EM</given-names></name></person-group><article-title>Global patterns of cancer incidence and mortality rates and trends</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2010</year><volume>19</volume><fpage>1893</fpage><lpage>907</lpage><pub-id pub-id-type="pmid">20647400</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jatoi</surname><given-names>I</given-names></name><name><surname>Anderson</surname><given-names>WF</given-names></name><name><surname>Rosenberg</surname><given-names>PS</given-names></name></person-group><article-title>Qualitative age-interactions in breast cancer: A tale of two diseases?</article-title><source>Am J Clin Oncol</source><year>2008</year><volume>31</volume><fpage>504</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">18838890</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagani</surname><given-names>O</given-names></name><name><surname>Senkus</surname><given-names>E</given-names></name><name><surname>Wood</surname><given-names>W</given-names></name><name><surname>Colleoni</surname><given-names>M</given-names></name><name><surname>Cufer</surname><given-names>T</given-names></name><name><surname>Kyriakides</surname><given-names>S</given-names></name><etal/></person-group><article-title>International guidelines for management of metastatic breast cancer: Can metastatic breast cancer be cured?</article-title><source>J Natl Cancer Inst</source><year>2010</year><volume>102</volume><fpage>456</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">20220104</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozikowski</surname><given-names>AP</given-names></name><name><surname>T&#x000fc;ckmantel</surname><given-names>W</given-names></name><name><surname>B&#x000f6;ttcher</surname><given-names>G</given-names></name><name><surname>Romanczyk</surname><given-names>LJ</given-names><suffix>Jr</suffix></name></person-group><article-title>Studies in polyphenol chemistry and bioactivity. 4.(1) Synthesis of trimeric, tetrameric, pentameric, and higher oligomeric epicatechin-derived procyanidins having all-beta, 8-interflavan connectivity and their inhibition of cancer cell growth through cell cycle arrest</article-title><source>J Org Chem</source><year>2003</year><volume>68</volume><fpage>1641</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">12608775</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramljak</surname><given-names>D</given-names></name><name><surname>Romanczyk</surname><given-names>LJ</given-names></name><name><surname>Metheny-Barlow</surname><given-names>LJ</given-names></name><name><surname>Thompson</surname><given-names>N</given-names></name><name><surname>Knezevic</surname><given-names>V</given-names></name><name><surname>Galperin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Pentameric procyanidin from <italic>Theobroma cacao</italic> selectively inhibits growth of human breast cancer cells</article-title><source>Mol Cancer Ther</source><year>2005</year><volume>4</volume><fpage>537</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">15827326</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faria</surname><given-names>A</given-names></name><name><surname>Calhau</surname><given-names>C</given-names></name><name><surname>de Freitas</surname><given-names>V</given-names></name><name><surname>Mateus</surname><given-names>N</given-names></name></person-group><article-title>Procyanidins as antioxidants and tumor cell growth modulators</article-title><source>J Agric Food Chem</source><year>2006</year><volume>54</volume><fpage>2392</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16536624</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goss&#x000e9;</surname><given-names>F</given-names></name><name><surname>Roussi</surname><given-names>S</given-names></name><name><surname>Guyot</surname><given-names>S</given-names></name><name><surname>Schoenfelder</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>A</given-names></name><name><surname>Bergerat</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Potentiation of apple procyanidin-triggered apoptosis by the polyamine oxidase inactivator MDL 72527 in human colon cancer-derived metastatic cells</article-title><source>Int J Oncol</source><year>2006</year><volume>29</volume><fpage>423</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16820885</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seiler</surname><given-names>N</given-names></name><name><surname>Chaabi</surname><given-names>M</given-names></name><name><surname>Roussi</surname><given-names>S</given-names></name><name><surname>Goss&#x000e9;</surname><given-names>F</given-names></name><name><surname>Lobstein</surname><given-names>A</given-names></name><name><surname>Raul</surname><given-names>F</given-names></name></person-group><article-title>Synergism between apple procyanidins and lysosomotropic drugs: Potential in chemoprevention</article-title><source>Anticancer Res</source><year>2006</year><volume>26</volume><fpage>3381</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17094456</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizarraga</surname><given-names>D</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Bried&#x000e9;</surname><given-names>JJ</given-names></name><name><surname>van Delft</surname><given-names>JH</given-names></name><name><surname>Touri&#x000f1;o</surname><given-names>S</given-names></name><name><surname>Centelles</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>The importance of polymerization and galloylation for the antiproliferative properties of procyanidin-rich natural extracts</article-title><source>FEBS J</source><year>2007</year><volume>274</volume><fpage>4802</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17824958</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Song</surname><given-names>I</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>SH</given-names></name><name><surname>Lisanti</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Selective cytotoxicity of synthesized procyanidin 3-O-galloylepicatechin-4b, 8-3-O-galloylcatechin to human cancer cells</article-title><source>Cell Cycle</source><year>2008</year><volume>7</volume><fpage>1648</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">18560275</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>T</given-names></name><name><surname>Chiba</surname><given-names>M</given-names></name><name><surname>Kasai</surname><given-names>K</given-names></name><name><surname>Nozaka</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Shoji</surname><given-names>T</given-names></name><etal/></person-group><article-title>Apple procyanidins induce tumor cell apoptosis through mitochondrial pathway activation of caspase-3</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>585</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">17827407</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nandakumar</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>T</given-names></name><name><surname>Katiyar</surname><given-names>SK</given-names></name></person-group><article-title>Multi-targeted prevention and therapy of cancer by proanthocyanidins</article-title><source>Cancer Lett</source><year>2008</year><volume>269</volume><fpage>378</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">18457915</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierini</surname><given-names>R</given-names></name><name><surname>Kroon</surname><given-names>PA</given-names></name><name><surname>Guyot</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>IT</given-names></name><name><surname>Belshaw</surname><given-names>NJ</given-names></name></person-group><article-title>The procyanidin-mediated induction of apoptosis and cell-cycle arrest in esophageal adenocarcinoma cells is not dependent on p21(Cip1/WAF1)</article-title><source>Cancer Lett</source><year>2008</year><volume>270</volume><fpage>234</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">18562088</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name></person-group><article-title>Biological activities of procyanidins from the bark of <italic>Pinus caribaea</italic> Morelet</article-title><source>Nat Prod Res</source><year>2009</year><volume>23</volume><fpage>696</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">19418352</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaszewska</surname><given-names>E</given-names></name><name><surname>Kosmider</surname><given-names>A</given-names></name><name><surname>Kiss</surname><given-names>AK</given-names></name><name><surname>Naruszewicz</surname><given-names>M</given-names></name></person-group><article-title><italic>Oenothera paradoxa</italic> defatted seeds extract containing pentagalloylglucose and procyanidins potentiates the cytotoxicity of vincristine</article-title><source>J Physiol Pharmacol</source><year>2010</year><volume>61</volume><fpage>637</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21081808</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>ET</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>D</given-names></name><name><surname>Phung</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>RE</given-names></name><name><surname>Young</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds</article-title><source>Cancer Res</source><year>2003</year><volume>63</volume><fpage>8516</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">14679019</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>KC</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>BJ</given-names></name><name><surname>Seong</surname><given-names>AR</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Shiota</surname><given-names>M</given-names></name><etal/></person-group><article-title>Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor</article-title><source>Biochem J</source><year>2011</year><volume>433</volume><fpage>235</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">20955177</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>C</given-names></name><name><surname>Veluri</surname><given-names>R</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name><name><surname>Chou</surname><given-names>SC</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name></person-group><article-title>Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3&#x02032;- di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells</article-title><source>Carcinogenesis</source><year>2007</year><volume>28</volume><fpage>1478</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">17331955</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>SC</given-names></name><name><surname>Kaur</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name><name><surname>Agarwal</surname><given-names>R</given-names></name><name><surname>Agarwal</surname><given-names>C</given-names></name></person-group><article-title>Influence of gallate esterification on the activity of procyanidin B2 in androgen-dependent human prostate carcinoma LNCaP cells</article-title><source>Pharm Res</source><year>2010</year><volume>27</volume><fpage>619</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">20162340</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group><article-title>Immunomodulatory and anticancer activities of flavonoids extracted from litchi (<italic>Litchi chinensis</italic>) pericarp</article-title><source>Int Immunopharmacol</source><year>2007</year><volume>7</volume><fpage>162</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17178382</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>AJS</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Gouv&#x000ea;a</surname></name></person-group><article-title>CMCP. Aqueous extract of <italic>Plinia edulis</italic> leaves: Antioxidant activity and cytotoxicity to human breast cancer MCF-7 cell line</article-title><source>S Afr J Bot</source><year>2012</year><volume>81</volume><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campanella</surname><given-names>NC</given-names></name><name><surname>da Silva Demartini</surname><given-names>M</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><name><surname>de Almeida</surname><given-names>ET</given-names></name><name><surname>Gouv&#x000ea;a</surname><given-names>CMCP</given-names></name></person-group><article-title>The cytotoxic and growth inhibitory effects of palladium (II) complexes on MDA-MB-435 cells</article-title><source>Genet Mol Biol</source><year>2012</year><volume>35</volume><fpage>159</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">22481890</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filho</surname><given-names>PR</given-names></name><name><surname>Ferreira</surname><given-names>LA</given-names></name><name><surname>Gouv&#x000ea;a</surname><given-names>CM</given-names></name></person-group><article-title>Protective action against chemical-induced genotoxicity and free radical scavenging activities of <italic>Stryphnodendron adstringens</italic> (&#x0201c;barbatim&#x000e3;o&#x0201d;) leaf extracts</article-title><source>Rev Bras Farmacogn</source><year>2011</year><volume>21</volume><fpage>1000</fpage><lpage>5</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>A</given-names></name><name><surname>Tiwari</surname><given-names>M</given-names></name><name><surname>Sinha</surname><given-names>RA</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Balapure</surname><given-names>AK</given-names></name><name><surname>Bajpai</surname><given-names>VK</given-names></name><etal/></person-group><article-title>Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>19762</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16679319</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahm</surname><given-names>HA</given-names></name><name><surname>Dunn</surname><given-names>VR</given-names></name><name><surname>Butash</surname><given-names>KA</given-names></name><name><surname>Deveraux</surname><given-names>WL</given-names></name><name><surname>Woster</surname><given-names>PM</given-names></name><name><surname>Casero</surname><given-names>RA</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines</article-title><source>Clin Cancer Res</source><year>2001</year><volume>7</volume><fpage>391</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11234895</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longley</surname><given-names>DB</given-names></name><name><surname>Boyer</surname><given-names>J</given-names></name><name><surname>Allen</surname><given-names>WL</given-names></name><name><surname>Latif</surname><given-names>T</given-names></name><name><surname>Ferguson</surname><given-names>PR</given-names></name><name><surname>Maxwell</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>2644</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11980662</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;nicke</surname><given-names>RU</given-names></name><name><surname>Sprengart</surname><given-names>ML</given-names></name><name><surname>Wati</surname><given-names>MR</given-names></name><name><surname>Porter</surname><given-names>AG</given-names></name></person-group><article-title>Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>9357</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9545256</pub-id></element-citation></ref></ref-list></back></article>